Corporate creativity follows a bell curve. Early-stage companies and those facing catastrophic failure (the tails) are forced to innovate. Most established companies exist in the middle, where repeating proven playbooks and playing it safe stifles true risk-taking.

True innovation requires leaders to adopt a venture capital mindset, accepting that roughly nine out of ten initiatives will fail. This high tolerance for failure, mirroring professional investment odds, is a prerequisite for the psychological safety needed for breakthrough results.

Great investment ideas are often idiosyncratic and contrary to conventional wisdom. A committee structure, which inherently seeks consensus and avoids career risk, is structurally incapable of approving such unconventional bets. To achieve superior results, talented investors must be freed from bureaucratic constraints that favor conformity.

Large institutions, even those designed to foster innovation, are fundamentally conservative. Their investments in real estate, careers, and the status quo make them inherently resistant to the revolutionary change that defines major breakthroughs.

To prevent stagnation, large, stable institutions like Liberty Mutual must deliberately build a culture where employees are incentivized to be curious and take entrepreneurial risks. This requires a governance structure that supports, rather than punishes, such behavior, which is crucial for attracting novel opportunities.

Disruptive ideas within large companies trigger an organizational "immune system response." Just as biological antibodies attack foreign invaders, the corporate structure, designed for predictability, attacks novel ideas, preventing radical innovation from taking root.

A key reason companies stagnate is the accumulation of "scar tissue": instituting a new, rigid policy for every minor mistake or negative interaction. This behavior creates a risk-averse culture that prevents the "controlled damage" necessary for exploration and rapid learning, ultimately slowing innovation to a halt.

Established companies operate an 'execution engine' that values predictability and eliminates failure. This directly conflicts with the 'innovation engine,' which requires uncertainty, experimentation, and learning from failure to discover future value. This fundamental tension is the primary reason corporate innovation initiatives often stall or fail.

Requiring every cost to link directly to a known revenue unit—a tight "fitness function"—optimizes for efficiency but kills exploration and luck. This approach produces predictable, incremental gains ("moss") but prevents the discovery of game-changing innovations ("sharks"), which require looser constraints to evolve.